Turner, J. Rick.
Key Statistical Concepts in Clinical Trials for Pharma [electronic resource] / by J. Rick Turner. - IX, 61p. 1 illus. online resource. - SpringerBriefs in Pharmaceutical Science & Drug Development, 1864-8118 . - SpringerBriefs in Pharmaceutical Science & Drug Development, .
This Brief discusses key statistical concepts that facilitate the inferential analysis of data collected from a group of individuals participating in a pharmaceutical clinical trial, the estimation of their clinical significance in the general population of individuals likely to be prescribed the drug if approved, and the related decision-making that occurs at both the public health level (by regulatory agencies when deciding whether or not to approve a new drug for marketing) and the individual patient level (by physicians and their patients when deciding whether or not the patient should be prescribed a drug that is on the market). These concepts include drug safety and efficacy, statistical significance, clinical significance, and benefit-risk balance.
9781461416623
10.1007/978-1-4614-1662-3 doi
Medicine.
Pharmaceutical technology.
Biomedicine.
Biomedicine general.
Pharmaceutical Sciences/Technology.
R-RZ
610
Key Statistical Concepts in Clinical Trials for Pharma [electronic resource] / by J. Rick Turner. - IX, 61p. 1 illus. online resource. - SpringerBriefs in Pharmaceutical Science & Drug Development, 1864-8118 . - SpringerBriefs in Pharmaceutical Science & Drug Development, .
This Brief discusses key statistical concepts that facilitate the inferential analysis of data collected from a group of individuals participating in a pharmaceutical clinical trial, the estimation of their clinical significance in the general population of individuals likely to be prescribed the drug if approved, and the related decision-making that occurs at both the public health level (by regulatory agencies when deciding whether or not to approve a new drug for marketing) and the individual patient level (by physicians and their patients when deciding whether or not the patient should be prescribed a drug that is on the market). These concepts include drug safety and efficacy, statistical significance, clinical significance, and benefit-risk balance.
9781461416623
10.1007/978-1-4614-1662-3 doi
Medicine.
Pharmaceutical technology.
Biomedicine.
Biomedicine general.
Pharmaceutical Sciences/Technology.
R-RZ
610